Analyst Research

Report Title Price
Thomson Reuters Stock Report - GEVO, INC. (GEVO-O)
Provider: Thomson Reuters Stock Report
$25.00
Buy
GEVO INC (GEVO) 12-months forecast
Provider: Pechala's Reports
$15.00
Buy
Gevo Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
ValuEngine Detailed Valuation Report for GEVO
Provider: ValuEngine, Inc.
$127.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Gevo Inc Receives Key Patent Covering Critical Technology To Enable Commercially Viable Yields Of Isobutanol Production From Yeast


Tuesday, 13 Mar 2012 08:00am EDT 

Gevo Inc announced today that the United States Patent and Trademark Office (USPTO) granted U.S. Patent No. 8,133,715, entitled “Reduced By-Product Accumulation for Improved Production of Isobutanol.” 

Latest Developments for Gevo Inc

Latest Key Developments in Renewable

Related Company News

Company Quote

Gevo Inc
(GEVO.OQ)
1.73
0.05 +2.98%
17 Jun 2013